TheraRadar

Pharma Intelligence, Simplified

← All Targets

PDE4

6 drugs
RespiratoryImmunology
Market Leader
OTEZLA
Amgen
4
approved indications
6
Approved Drugs
5
Companies
10
Indications
2
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (5 companies)
All 6 approved drugs
Therapeutic area breakdown
Full indication list (10 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Amgen 2 drugs
SENORES PHARMS 1 drug
ARCUTIS 1 drug

By Therapeutic Area

Respiratory 3 drugs
Immunology 2 drugs